NeuroSigma Announces Acceptance into 2024 Cohort of the KidsX Accelerator Program
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program .
- LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the KidsX Accelerator Program .
- NeuroSigma is a Los Angeles-based bioelectronics company focused on external trigeminal nerve stimulation (eTNS) technology for the treatment of neurological and neuropsychiatric disorders.
- “We are honored to be accepted into the KidsX 2024 accelerator program.
- The device is a wearable, home-use neurostimulation product, and was accepted into the KidsX Pediatric Mental and Behavioral Health focus area.